Gene testing is important in the diagnosis of prolonged QT syndrome and hypertrophic cardiomyopathy, which should be diagnosed already at an asymptomatic stage. An international expert group has recently given recommendations concerning the use of gene tests in the clinical diagnostics of cardiac rhythm disturbances and cardiomyopathies. In these patients diagnostics is demanding and time consuming due to familial aggregation of the diseases. Thus, to facilitate appropriate use of gene testing, the diagnostics should be centralized.